COVID-19 -

May 19, 2022
Medicinal Products,
Pharmacovigilance
Pharmacovigilance - A Regulatory Synopsis
March 31, 2022
Medical Devices,
Regulatory Affairs
EU Notified Bodies (NBs) Updates and MDR & IVDR Implementation Challenges
March 29, 2022
Medicinal Products,
Regulatory Affairs
The Why and How of FDA’s Emergency Use Authorizations
December 17, 2021
Medical Devices,
Regulatory Affairs
MHRA Extends the Free PPE Scheme till March 21, 2022
November 10, 2021
Medicinal Products,
Medical & Scientific Communication
TGA’s Permission Guidance (2021) for a Compliant Communication Environment
November 3, 2021
Chemicals
FDA’s Update on Biosimilars and Interchangeability Status for BLAs
March 1, 2021
Medical Devices,
Market Access
Health Canada Releases Notice on Research Use Only COVID-19 Tests
January 25, 2021
Medical Devices,
EU Compliance
US FDA Releases a New Enforcement Policy for Coagulation Systems
January 5, 2021
Medical Devices,
Digital Health
Medical Devices Global Regulatory Landscape - A Throwback into Year 2020
January 5, 2021
Medical Devices,
Regulatory Affairs
Medical Device Regulatory Affairs in the USA During COVID-19 – Decode the USFDA’s FAQs
October 13, 2020
Medical Devices,
Market Access
Medical Devices Registrations During COVID-19 - US FDA Procedures
October 13, 2020
Medical Devices,
Regulatory Affairs
COFEPRIS Introduces New Electronic Appointment System for Medical Device Registrants